Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telaprevir in Pediatric Genotype 1 Hepatitis C
NCT01701063Phase 2Terminated
- Sponsor
- Vertex Pharmaceuticals
- Start
- Jan 2013
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of telaprevir in hepatitis C (HCV), sponsored by Vertex Pharmaceuticals. Started Jan 2013; status: terminated.
02
Drugs
telaprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01701063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01701063.